![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PXMP2 |
Gene summary for PXMP2 |
![]() |
Gene information | Species | Human | Gene symbol | PXMP2 | Gene ID | 5827 |
Gene name | peroxisomal membrane protein 2 | |
Gene Alias | MPV17L3 | |
Cytomap | 12q24.33 | |
Gene Type | protein-coding | GO ID | GO:0008150 | UniProtAcc | Q9NR77 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5827 | PXMP2 | LZE20T | Human | Esophagus | ESCC | 4.76e-03 | 1.34e-01 | 0.0662 |
5827 | PXMP2 | LZE22T | Human | Esophagus | ESCC | 1.27e-02 | 3.70e-01 | 0.068 |
5827 | PXMP2 | LZE24T | Human | Esophagus | ESCC | 7.39e-11 | 2.98e-01 | 0.0596 |
5827 | PXMP2 | P1T-E | Human | Esophagus | ESCC | 8.50e-07 | 3.29e-01 | 0.0875 |
5827 | PXMP2 | P2T-E | Human | Esophagus | ESCC | 2.00e-57 | 1.23e+00 | 0.1177 |
5827 | PXMP2 | P4T-E | Human | Esophagus | ESCC | 6.60e-33 | 7.45e-01 | 0.1323 |
5827 | PXMP2 | P5T-E | Human | Esophagus | ESCC | 1.37e-25 | 5.65e-01 | 0.1327 |
5827 | PXMP2 | P8T-E | Human | Esophagus | ESCC | 3.58e-25 | 4.24e-01 | 0.0889 |
5827 | PXMP2 | P10T-E | Human | Esophagus | ESCC | 1.61e-32 | 5.48e-01 | 0.116 |
5827 | PXMP2 | P11T-E | Human | Esophagus | ESCC | 5.21e-11 | 4.72e-01 | 0.1426 |
5827 | PXMP2 | P12T-E | Human | Esophagus | ESCC | 1.43e-20 | 3.48e-01 | 0.1122 |
5827 | PXMP2 | P15T-E | Human | Esophagus | ESCC | 5.44e-13 | 2.86e-01 | 0.1149 |
5827 | PXMP2 | P16T-E | Human | Esophagus | ESCC | 2.68e-26 | 5.74e-01 | 0.1153 |
5827 | PXMP2 | P17T-E | Human | Esophagus | ESCC | 8.26e-12 | 4.24e-01 | 0.1278 |
5827 | PXMP2 | P19T-E | Human | Esophagus | ESCC | 4.24e-05 | 4.72e-01 | 0.1662 |
5827 | PXMP2 | P20T-E | Human | Esophagus | ESCC | 2.41e-15 | 3.50e-01 | 0.1124 |
5827 | PXMP2 | P21T-E | Human | Esophagus | ESCC | 7.92e-69 | 1.36e+00 | 0.1617 |
5827 | PXMP2 | P22T-E | Human | Esophagus | ESCC | 3.44e-23 | 4.53e-01 | 0.1236 |
5827 | PXMP2 | P23T-E | Human | Esophagus | ESCC | 5.71e-21 | 5.13e-01 | 0.108 |
5827 | PXMP2 | P24T-E | Human | Esophagus | ESCC | 1.22e-17 | 3.08e-01 | 0.1287 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Cervix | N_HPV | ![]() |
Endometrium | AEH | ![]() |
Endometrium | EEC | ![]() |
Prostate | BPH | ![]() |
Prostate | Tumor | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa041467 | Esophagus | ESCC | Peroxisome | 55/4205 | 82/8465 | 1.04e-03 | 3.27e-03 | 1.68e-03 | 55 |
hsa0414612 | Esophagus | ESCC | Peroxisome | 55/4205 | 82/8465 | 1.04e-03 | 3.27e-03 | 1.68e-03 | 55 |
hsa041462 | Liver | Cirrhotic | Peroxisome | 36/2530 | 82/8465 | 4.79e-03 | 1.74e-02 | 1.07e-02 | 36 |
hsa041463 | Liver | Cirrhotic | Peroxisome | 36/2530 | 82/8465 | 4.79e-03 | 1.74e-02 | 1.07e-02 | 36 |
hsa041464 | Liver | HCC | Peroxisome | 58/4020 | 82/8465 | 1.57e-05 | 1.05e-04 | 5.85e-05 | 58 |
hsa041465 | Liver | HCC | Peroxisome | 58/4020 | 82/8465 | 1.57e-05 | 1.05e-04 | 5.85e-05 | 58 |
hsa041466 | Oral cavity | OSCC | Peroxisome | 47/3704 | 82/8465 | 9.01e-03 | 2.01e-02 | 1.03e-02 | 47 |
hsa0414611 | Oral cavity | OSCC | Peroxisome | 47/3704 | 82/8465 | 9.01e-03 | 2.01e-02 | 1.03e-02 | 47 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PXMP2 | SNV | Missense_Mutation | novel | c.171N>T | p.Lys57Asn | p.K57N | Q9NR77 | protein_coding | tolerated(0.05) | benign(0.17) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PXMP2 | SNV | Missense_Mutation | c.267C>G | p.Phe89Leu | p.F89L | Q9NR77 | protein_coding | tolerated(0.18) | benign(0.005) | TCGA-MY-A5BE-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
PXMP2 | SNV | Missense_Mutation | rs746666562 | c.346G>A | p.Val116Ile | p.V116I | Q9NR77 | protein_coding | tolerated(1) | benign(0.001) | TCGA-VS-A94Z-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
PXMP2 | SNV | Missense_Mutation | rs765325030 | c.340N>T | p.Arg114Cys | p.R114C | Q9NR77 | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-A6-6781-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | SD |
PXMP2 | SNV | Missense_Mutation | c.562G>A | p.Ala188Thr | p.A188T | Q9NR77 | protein_coding | tolerated(0.44) | benign(0.027) | TCGA-AD-6889-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | xeloda | PD | |
PXMP2 | SNV | Missense_Mutation | rs200781916 | c.176N>A | p.Arg59Gln | p.R59Q | Q9NR77 | protein_coding | tolerated(0.51) | benign(0.005) | TCGA-D5-6928-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
PXMP2 | deletion | Frame_Shift_Del | novel | c.178delN | p.Glu62LysfsTer12 | p.E62Kfs*12 | Q9NR77 | protein_coding | TCGA-AA-3949-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | ||
PXMP2 | SNV | Missense_Mutation | rs746666562 | c.346G>A | p.Val116Ile | p.V116I | Q9NR77 | protein_coding | tolerated(1) | benign(0.001) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
PXMP2 | SNV | Missense_Mutation | rs201360859 | c.421G>A | p.Ala141Thr | p.A141T | Q9NR77 | protein_coding | tolerated(0.49) | benign(0.143) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
PXMP2 | SNV | Missense_Mutation | novel | c.356N>A | p.Pro119Gln | p.P119Q | Q9NR77 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AP-A0LS-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |